S'abonner

Comparison of intravascular access methods applied by nurses wearing personal protective equipment in simulated COVID-19 resuscitation: A randomized crossover simulation trial - 29/10/21

Doi : 10.1016/j.ajem.2021.05.080 
Anna Drozd, MD a, Jacek Smereka, PhD, MD b, Michal Pruc, MS a, Marek Malysz, MSc, EMT-P a, Aleksandra Gasecka, PhD, MD c, d, Leyla Ozturk Sonmez, PhD, MD e, Maciej Cyran, MD f, Lars Konge, PhD g, Lukasz Szarpak, PhD, MBA a, h,
a Polish Society of Disaster Medicine, Warsaw, Poland 
b Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland 
c Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands 
d 1st Chair and Department of Cardiology, Medical University of Warsaw, Poland 
e Department of Emergency Medicine, Beyhekim Training and Research Hospital, Konya, Turkey 
f Maria Sklodowska-Curie Medical Academy in Warsaw, Poland 
g Copenhagen Academy for Medical Education and Simulation, Centre for HR and Education, University of Copenhagen, Copenhagen, Denmark 
h Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland 

Corresponding author at: Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.Maria Sklodowska-Curie Bialystok Oncology CenterBialystokPoland

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Prehospital emergency care of children is challenging. In the era of the COVID-19 pandemic, when medical personnel should use personal protective equipment against aerosol-generating procedures, the efficiency of medical procedures may decrease. The study objective was to evaluate the effectiveness of different intravascular access methods applied by nurses wearing biosafety Level-2 suits in simulated paediatric COVID-19 resuscitation.

Methods

A prospective, randomized, crossover, single-blinded simulation trial was performed. Nursing staff attending Advanced Cardiovascular Life Support courses accredited by the American Heart Association participated in the study. A total of 65 nurses were recruited and randomly assigned to different study groups. They received standard training on intravascular access methods employing distinct devices. The participants wore biosafety Level-2 suits and performed vascular access with the following intraosseous devices: NIO-P, EZ-IO, and Jamshidi needle; intravenous (IV) access was used as a reference method. Both the order of participants and the access methods were random. Each participant performed intravascular access with each of the four methods tested. The effectiveness of the first attempt to obtain intravascular access and the following time parameters were analysed: the time between grasping the intravascular device out of the original packing until infusion line connection. The ease of the procedure was measured with a visual analogue scale (1 – easy; 10 – difficult).

Results

The first attempt success rate of intravascular access by using NIO-P and EZ-IO equalled 100% and was statistically significantly higher than that with the Jamshidi needle (80.0%; p = 0.02) and with the IV method (69.2%; p = 0.005). The time required to connect the infusion line varied and amounted to 33 ± 4 s for NIO-P compared to 37 ± 6.7 s for EZ-IO (p < 0.001), 43 ± 7 s for Jamshidi (p < 0.001), and 98.5 ± 10 s for IV access (p < 0.001). The procedure was easiest in the case of NIO-P and EZ-IO (2 ± 1 points; p = 1.0) compared with Jamshidi (5 ± 3 points; p < 0.001) and IV access (7 ± 2 points; p < 0.001).

Conclusion

The study provides evidence that nurses wearing biosafety Level-2 suits were able to obtain intraosseous access faster and more effectively as compared with IV access during simulated COVID-19 paediatric resuscitation. The most effective method of intravascular access was the NIO-P intraosseous device. Further clinical trials are necessary to confirm the results.

Le texte complet de cet article est disponible en PDF.

Keywords : Intraosseous access, Intravascular access, Child, Cardiopulmonary resuscitation, Personal protective equipment, COVID-19, SARS-CoV-2, Coronavirus, Infection, Medical simulation

Abbreviations : AGP, CI, IO, IRB, IV, MD, OR, PPE


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 49

P. 189-194 - novembre 2021 Retour au numéro
Article précédent Article précédent
  • Association between patients' body mass index and emergency department wait times: A multicenter observational cohort investigation by the reducing disparities increasing equity in emergency medicine (REDEEM) study group
  • Isabella M. Lichen, Venkatesh R. Bellamkonda, Ronna L. Campbell, Sean M. Phelan, Joel R. Anderson, Aidan F. Mullan, Kit Knier, Annie T. Sadosty
| Article suivant Article suivant
  • Prehospital, post-ROSC blood pressure and associated neurologic outcome
  • Jeremy Lacocque, Lee Siegel, Karl A. Sporer

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.